Pain/neuralgia
Conditions
Interventions
None listed
Sponsors
Nihon Chouzai Co.,Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Persons aged 20 and over at the time of informed consent 2) A person who has been prescribed only one study drug for 90 consecutive days or more (with or without concomitant use of a therapeutic drug other than a drug for pain indication) 3) Those who have sufficient communication skills to participate in this study 4) Those who are being treated at a Japanese medical institution 5) Person who came for the purpose of pain relief 6) Those who agreed to participate in this study
Exclusion criteria
Exclusion criteria: 1) Those who have the following possibilities within the past 90 days when obtaining consent i) I was given pain treatment by injection ii) Using oral medications other than the study drug (including OTC) for the purpose of pain relief 2) Those who are pregnant or may be pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient satisfaction with NEP/non-NEP treatment. 5-point scale:Dissatisfied/ Slightly Dissatisfied/Neither/Slightly Satisfied/Satisfied | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain relief 2. Improvement of daily life movement (ADL) 3. Degree of communication between doctor and patient <Patient background> 4. medical department that received treatment, gender, age, area 5. Drugs prescribed at the survey pharmacy last time and their prescribed amounts 6. NeP screening score (neuropathic pain screening questionnaire) 7. Pain score (NRS) | — |
Countries
Japan
Contacts
Public Contactsatoshi yuge
Nihon Chouzai Co.,Ltd. x
Outcome results
None listed